Home  >  News
Eppen_Webinar_June2025
you can get e-magazine links on WhatsApp. Click here
News
  PTC Therapeutics’ Sephience gets European marketing authorization to treat children and adults living with phenylketonuria,   June 24, 2025
  EMA accepts GSK’s MAA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis,   June 24, 2025
  Ratio Therapeutics & TerraPower Isotopes ink supply pact for actinium-225 for targeted radiotherapeutics,   June 23, 2025
  EMA committee recommends marketing approval for Bayer’s Nubeqa for patients with advanced prostate cancer,   June 21, 2025
  Saptalis Pharma launches fluoxetine oral solution, USP 20 mg/5 mL for treatment of mental health conditions,   June 20, 2025
  Ratio Therapeutics & Nusano ink long-term, multi-isotope supply agreement to boost production of cancer radiopharmaceuticals,   June 19, 2025
  Doceree presents Season 2 podcast on AI data-driven pharma marketing,   June 19, 2025
  Abbott & MSD ink strategic pact to distribute innovative oral anti-diabetic medicines in India,   June 19, 2025
  HELP Therapeutics and China Resources Sanjiu partner to co-develop and commercialize HiCM-188 for advanced heart failure,   June 18, 2025
  Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China,   June 16, 2025
  Chiesi Group signs global licensing pact with Key2Brain to advance BBB-crossing therapies for lysosomal storage disorders,   June 14, 2025
  Shilpa Medicare inks commercial supply deal with Orion for innovative recombinant human albumin,   June 13, 2025
  Axsome Therapeutics introduces Symbravo in US for acute treatment of migraine with or without aura in adults,   June 11, 2025
  Citius Oncology inks distribution services agreement with Cardinal Health,   June 11, 2025
  Harrow acquires US commercial rights to Byqlovi 0.05% from Formosa Pharma,   June 10, 2025
  Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season,   June 10, 2025
  Telix’s Illuccix PSMA-PET imaging agent receives German approval,   June 09, 2025
  Ocugen signs binding term sheet for license of OCU400 modifier gene therapy for retinitis pigmentosa in Korea,   June 07, 2025
  UK MHRA approves SFL Pharmaceuticals’ aumolertinib to treat non-small cell lung cancer,   June 04, 2025
  Outlook Therapeutics introduces Lytenava in Germany & UK for the treatment of wet AMD,   June 03, 2025

  • Results Found: 6988
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 350
 Back
 
Avians_2025
analytica_Lab_India
CPHISEA25
CPHI_PMEC_China_2025
Pharmatech_Lab_Expo2025
CPHI_Hi_Korea_2025
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram